Recombinant Saccharomyces cerevisiae ERG11 Protein ，GST

ERG11, also known as lanosterol 14α-demethylase, is a crucial enzyme in the ergosterol biosynthesis pathway, which is essential for the viability of various fungi, including pathogenic species such as Candida albicans and Aspergillus fumigatus. The enzyme catalyzes the demethylation of lanosterol, a precursor in the synthesis of ergosterol, which is a key component of fungal cell membranes. Due to its vital role in fungal biology, ERG11 represents an important target for antifungal drug development. Azole antifungals, such as fluconazole and itraconazole, inhibit ERG11, thereby disrupting ergosterol synthesis and compromising fungal cell membrane integrity. However, the emergence of azole-resistant fungal strains poses a significant challenge in clinical settings, making studies on ERG11 vital for understanding resistance mechanisms and developing new therapeutic strategies. Research on the recombinant expression of ERG11 can provide insights into its structure, function, and interaction with inhibitors, paving the way for the design of novel antifungals. Additionally, studying ERG11 can enhance our understanding of the evolutionary adaptations in fungal pathogens and assist in the identification of specific resistance mutations. Increasing knowledge about this enzyme is essential for overcoming current limitations in antifungal therapies and can lead to improved treatment options for invasive fungal infections, a growing concern in immunocompromised populations worldwide.